Moors & Cabot, Inc. Idexx Laboratories Inc Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Moors & Cabot, Inc. holds 415 shares of IDXX stock, worth $173,154. This represents 0.01% of its overall portfolio holdings.

Number of Shares

415

Holding current value

$173,154

% of portfolio

0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$455.08 - $517.19 $188,858 - $214,633	415 New	415 $209,000
Q4 2022 Feb 09, 2023	SELL	$324.64 - $441.27 $158,424 - $215,339	-488 Reduced 29.87%	1,146 $467,000
Q4 2022 Feb 06, 2023	BUY	$324.64 - $441.27 $153,554 - $208,720	473 Added 40.74%	1,634 $666,000
Q3 2022 Nov 07, 2022	SELL	$325.8 - $407.78 $55,711 - $69,730	-171 Reduced 12.84%	1,161 $378,000
Q2 2022 Aug 08, 2022	SELL	$327.37 - $553.44 $139,132 - $235,212	-425 Reduced 24.19%	1,332 $467,000
Q1 2022 May 13, 2022	BUY	$466.52 - $631.01 $24,259 - $32,812	52 Added 3.05%	1,757 $961,000
Q4 2021 Feb 14, 2022	SELL	$586.54 - $666.48 $123,173 - $139,960	-210 Reduced 10.97%	1,705 $1.12 Million
Q3 2021 Dec 08, 2021	SELL	$621.9 - $705.76 $12.4 Million - $14 Million	-19,885 Reduced 91.22%	1,915 $1.19 Million
Q3 2021 Nov 05, 2021	BUY	$621.9 - $705.76 $12.5 Million - $14.1 Million	20,041 Added 1139.34%	21,800 $290,000
Q2 2021 Aug 10, 2021	SELL	$486.36 - $637.08 $14,590 - $19,112	-30 Reduced 1.68%	1,759 $1.11 Million
Q1 2021 May 12, 2021	SELL	$465.18 - $551.79 $888,493 - $1.05 Million	-1,910 Reduced 51.64%	1,789 $877,000
Q4 2020 Feb 11, 2021	SELL	$383.85 - $499.87 $74,083 - $96,474	-193 Reduced 4.96%	3,699 $1.85 Million
Q3 2020 Nov 09, 2020	SELL	$334.54 - $406.31 $107,052 - $130,019	-320 Reduced 7.6%	3,892 $1.53 Million
Q2 2020 Aug 13, 2020	SELL	$230.66 - $330.16 $24,449 - $34,996	-106 Reduced 2.45%	4,212 $1.39 Million
Q1 2020 May 12, 2020	SELL	$182.94 - $290.97 $64,211 - $102,130	-351 Reduced 7.52%	4,318 $1.04 Million
Q4 2019 Jan 28, 2020	SELL	$248.66 - $285.01 $87,776 - $100,608	-353 Reduced 7.03%	4,669 $1.22 Million
Q3 2019 Oct 22, 2019	BUY	$260.07 - $289.93 $81,922 - $91,327	315 Added 6.69%	5,022 $1.37 Million
Q2 2019 Jul 18, 2019	BUY	$215.53 - $275.33 $266,610 - $340,583	1,237 Added 35.65%	4,707 $1.3 Million
Q1 2019 May 06, 2019	SELL	$178.02 - $225.69 $617,729 - $783,144	-3,470 Reduced 50.0%	3,470 $774,000
Q1 2019 May 01, 2019	BUY	$178.02 - $225.69 $644,432 - $816,997	3,620 Added 109.04%	6,940 $1.55 Million
Q4 2018 Feb 13, 2019	SELL	$176.18 - $248.92 $17,618 - $24,892	-100 Reduced 2.92%	3,320 $618,000
Q3 2018 Nov 14, 2018	BUY	$218.82 - $254.46 $135,668 - $157,765	620 Added 22.14%	3,420 $852,000
Q2 2018 Aug 14, 2018	BUY	$185.56 - $227.9 $64,018 - $78,625	345 Added 14.05%	2,800 $611,000
Q1 2018 May 18, 2018	BUY	$157.81 - $204.73 $387,423 - $502,612	2,455 New	2,455 $470,000

Others Institutions Holding IDXX

# of Institutions

1,210

Shares Held

73.3M

Call Options Held

167K

Put Options Held

343K

Vanguard Group Inc Valley Forge, PA

9.7M
Shares

$4.05 Billion
0.09% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$4.01 Billion
0.11% of portfolio
State Street Corp Boston, MA

3.61M
Shares

$1.51 Billion
0.08% of portfolio
Alliancebernstein L.P. New York, NY

2.82M
Shares

$1.18 Billion
0.5% of portfolio
Terry Smith Fundsmith LLP | London, X0

2.66M
Shares

$1.11 Billion
5.45% of portfolio

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $34.7B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account